Featured

  • August 7, 2025
  • North America
  • Healthcare

Boehringer and Click Therapeutics’ investigational prescription digital therapeutic CT-155 meets primary endpoint in CONVOKE study for negative symptoms in schizophrenia

CT-155 showed a reduction in experiential negative symptoms as an adjunct to standard of care antipsychotic therapy from baseline to week 16, as measured by CAINS-MAP. CT-155 is an investigational prescription digital therapeutic being evaluated to target negative symptoms of schizophrenia in…

Read More

  • June 4, 2025
  • North America
  • Healthcare

Highridge Medical, an H.I.G. Capital Portfolio Company, Completes Divestiture of its Bone Healing Division

MIAMI – June 4, 2025 – H.I.G. Capital (“H.I.G.”), a leading global alternative investment firm with $70 billion of capital under management, is pleased to announce that its portfolio company, Highridge Medical (“Highridge”), has completed the sale of its EBI Bone Healing…

Read More

All Releases

Reset Filters

  • May 8, 2025
  • North America
  • Healthcare

Exagen Inc. Prices Public Offering of Common Stock

CARLSBAD, CA – May 8, 2025 – Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced the pricing of its previously announced underwritten public offering of 3,350,000 shares of its common stock at a public offering price of $5.25 per share. …

Read More

  • April 24, 2025
  • North America
  • Healthcare

Augmedics Completes 10,000th Augmented Reality Spine Surgery With xvision Spine System

CHICAGO – April 22, 2025 – Augmedics, a pioneer in augmented reality (AR) surgical navigation, today announced it has treated 10,000 patients with the xvision Spine System®. The landmark achievement marks a new record for the use of augmented reality navigation …

Read More

  • April 15, 2025
  • North America
  • Healthcare

Click Therapeutics Announces FDA Marketing Authorization for CT-132, the First Prescription Digital Therapeutic for the Preventive Treatment of Episodic Migraine in the United States

NEW YORK, NY – April 15, 2025 – Click Therapeutics, Inc., (“Click”) a leader in prescription medical treatments as both prescription digital therapeutics and software-enhanced drug™ therapies, has obtained FDA marketing authorization for the first prescription digital therapeutic for the preventive …

Read More

  • March 19, 2025
  • Europe
  • Healthcare

Dassault Systèmes Intensifies the MEDIDATA Commitment to Patient Experience with Investment in Click Therapeutics for Digital Therapeutics beyond Clinical Trials

Velizy-Villacoublay, France – March 19, 2025 Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced its investment in Click Therapeutics, a leader in prescription digital therapeutics and software-enhanced drug therapies. The transaction advances Dassault Systèmes’ transformation of the patient experience in …

Read More

  • February 19, 2025
  • North America
  • Healthcare

On Target Laboratories Awarded “Most Innovative Product of the Year” by Best in Biz – On Target

West Lafayette, IN – February 19, 2025 – On Target Laboratories is pleased to share it has been named a Gold Winner in the 2024 Best in Biz awards. The company’s product, CYTALUX® (pafolacianine) injection, was recognized in the “Most Innovative Product of …

Read More

  • September 23, 2024
  • North America
  • Healthcare

H.I.G. Capital Completes the Sale of BIOVECTRA

MIAMI – September 23, 2024 – H.I.G. Capital (“H.I.G.”), a leading global alternative investment firm with $65 billion of capital under management, is pleased to announce the sale of its portfolio company, BIOVECTRA Inc. (“BIOVECTRA” or the “Company”), a leading …

Read More

  • April 1, 2024
  • North America
  • Healthcare

H.I.G. Capital Acquires the Spine Business of ZimVie Rebranded as Highridge Medical

MIAMI – April 1, 2024 – H.I.G. Capital (“H.I.G.”), a leading global alternative investment firm with $60 billion of capital under management, is pleased to announce that one of its affiliates has completed the acquisition of the Spine division of …

Read More

  • January 3, 2024
  • North America
  • Healthcare

On Target Laboratories Names Scott Huennekens as Executive Chairperson of the Board

WEST LAFAYETTE, IN – January 3, 2024 – On Target Laboratories, Inc., a privately held biotechnology company developing intraoperative molecular imaging agents to target and illuminate cancer during surgery, today announced the appointment of Scott Huennekens as Executive Chairperson of the Board. A 30-year …

Read More

  • November 16, 2023
  • North America
  • Healthcare

On Target Laboratories Secures $30 Million for Commercialization of CYTALUX® (pafolacianine) injection

WEST LAFAYETTE, IN – November 16, 2023 – On Target Laboratories, Inc., a privately held biotechnology company developing intraoperative molecular imaging agents to target and illuminate cancer during surgery, today announced the completion of a $30 million Series C financing. This significant investment …

Read More

  • September 19, 2023
  • North America
  • Healthcare

Rising Pharmaceuticals Bolsters U.S. Supply Chain by Expanding Sterile Dosage Capabilities, Including Injectables and Ophthalmics, with Opening of New Facility

EAST BRUNSWICK, N.J. – September 19, 2023 – Rising Pharma Holdings Inc., dba as Rising Pharmaceuticals, today announced the opening of a commercial manufacturing facility in Decatur, Illinois, to manufacture and package sterile products, including injectables and ophthalmic products in …

Read More

Displaying 10 of 202 News Articles

×